Ohio prompted to scrutinize drug compounding operations

by lmallernee | October 22nd, 2012

October 22, 2012

In the wake of a deadly outbreak of fungal meningitis, the Ohio State Board of Pharmacy wants to do a better job with the state’s compounding pharmacy industry. On Friday, the board suspended the license of a compounding pharmacy in Piqua, Ohio, reports The Columbia Dispatch.

The board said that JAH Pharmacies “failed to properly separate a compounding pharmacy from a retail Medicine Shoppe; fell short of sterility standards; used outdated drug stock; and illegally manufactured drugs that weren’t compounded for a patient-specific legitimate prescription.”

A spokesperson for the Medicine Shoppe disputed those allegations and said that JAH tested all products for sterility and potency.  The Medicine Shoppe will remain open “and has nothing to do with JAH Pharmacies,” he said.

So far, 23 deaths have been reported due to fungal meningitis. There have been reports of 284 infections in 16 states—11 in Ohio.

According to the pharmacy board, about 430 Ohioans have received steroid injections that might have been tainted.

On October 9, the Ohio pharmacy board suspended the license of the compounding pharmacy in Massachusetts, New England Compounding Center from which the fungal meningitis originated.

“Whatever results from this must not disrupt legitimate patient care,” said a spokesman for the International Academy of Compounding Pharmacists.

If you or a loved one developed fungal meningitis from steroid injections, the Ohio personal injury lawyers at Nurenberg, Paris, Heller & McCarthy may be able to help.